| Name | Cvs Pharmacy #16303 |
|---|---|
| Organization Name | Highland Park Cvs Llc |
| Location | 6601 Grand Ave, Gurnee, Illinois 60031 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (847) 244-4299 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
SanBio, Inc. has announced that a patient at Stanford University Medical Center has become the first to be treated with SB623, a novel cell therapy for patients with disability resulting from ischemic stroke.
NovaSterilis today received a $100,000 Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) for developing a supercritical CO2 process to sterilize absorbable sutures and advanced biomaterials. The grant funds a collaboration with Chih-Chang Chu Ph.D, a pioneer in absorbable polymer development at Cornell University.
Sara Wittner had seemingly gotten her life back under control. After a December relapse in her battle with drug addiction, the 32-year-old completed a 30-day detox program and started taking a monthly injection to block her cravings for opioids.
ImmunoCellular Therapeutics today announced the results of a study in which it was shown that certain specific antigens are highly expressed on cancer stem cells (CSCs). This suggests that IMUC's lead cancer vaccine product candidate ICT-107, which targets those antigens, may effectively target not only the cells that make up the bulk of certain cancerous tumors, but also the CSCs that are widely believed to give rise to them and cause their recurrence.
› Verified 3 days ago
| NPI Number | 1538181342 |
| Organization Name | HIGHLAND PARK CVS LLC |
| Doing Business As | CVS PHARMACY #16303 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 6601 Grand Ave, Gurnee, IL 60031 |
| Phone Number | 847-244-4299 |
News Archive
SanBio, Inc. has announced that a patient at Stanford University Medical Center has become the first to be treated with SB623, a novel cell therapy for patients with disability resulting from ischemic stroke.
NovaSterilis today received a $100,000 Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) for developing a supercritical CO2 process to sterilize absorbable sutures and advanced biomaterials. The grant funds a collaboration with Chih-Chang Chu Ph.D, a pioneer in absorbable polymer development at Cornell University.
Sara Wittner had seemingly gotten her life back under control. After a December relapse in her battle with drug addiction, the 32-year-old completed a 30-day detox program and started taking a monthly injection to block her cravings for opioids.
ImmunoCellular Therapeutics today announced the results of a study in which it was shown that certain specific antigens are highly expressed on cancer stem cells (CSCs). This suggests that IMUC's lead cancer vaccine product candidate ICT-107, which targets those antigens, may effectively target not only the cells that make up the bulk of certain cancerous tumors, but also the CSCs that are widely believed to give rise to them and cause their recurrence.
› Verified 3 days ago
News Archive
SanBio, Inc. has announced that a patient at Stanford University Medical Center has become the first to be treated with SB623, a novel cell therapy for patients with disability resulting from ischemic stroke.
NovaSterilis today received a $100,000 Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) for developing a supercritical CO2 process to sterilize absorbable sutures and advanced biomaterials. The grant funds a collaboration with Chih-Chang Chu Ph.D, a pioneer in absorbable polymer development at Cornell University.
Sara Wittner had seemingly gotten her life back under control. After a December relapse in her battle with drug addiction, the 32-year-old completed a 30-day detox program and started taking a monthly injection to block her cravings for opioids.
ImmunoCellular Therapeutics today announced the results of a study in which it was shown that certain specific antigens are highly expressed on cancer stem cells (CSCs). This suggests that IMUC's lead cancer vaccine product candidate ICT-107, which targets those antigens, may effectively target not only the cells that make up the bulk of certain cancerous tumors, but also the CSCs that are widely believed to give rise to them and cause their recurrence.
› Verified 3 days ago
Osco Drug #3405 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 6507 Grand Ave, Gurnee, Illinois 60031 Phone: (847) 855-0990 | |
Balanced Living Chiropractice And W Type: DME Supplier - Customized Equipment Location: 495 N Riverside Dr, Gurnee, Illinois 60031 Phone: (847) 599-9900 | |
Eye Care Center Of Lake County Type: Durable Medical Equipment & Medical Supplies Supplier Location: 310 S Greenleaf St, Gurnee, Illinois 60031 Phone: (847) 244-1657 | |
Hanger Clinic Type: Durable Medical Equipment & Medical Supplies Supplier Location: 35 Tower Ct Ste C, Gurnee, Illinois 60031 Phone: (847) 623-6080 | |
Cvs Pharmacy #16303 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 6601 Grand Ave, Gurnee, Illinois 60031 Phone: (847) 244-4299 |